Biotech News
-
Predictmedix and Paras Defence & Space Technologies Are Joining Forces to Launch Predictmedix’s Proprietary Technologies in the Government and Public Sectors
November 19, 2020 (Source) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that the company is…
-
Predictive AI Provides Update on Sales Process and Pipeline
November 18, 2020 (Source) — Predictiv AI Inc. (TSX VENTURE: PAI) (OTC: INOTF) (FRANKFURT: 71TA) (“Predictiv AI” or the “Company”), www.predictiv.ai,…
-
StageZero Life Sciences Ltd. Provides Update on Financial Statements
November 17, 2020 (Source) — StageZero Life Sciences Ltd. (TSX:SZLS) (“StageZero”, or the “Company”) announces that it is restating…
-
StageZero Life Sciences Named as COVID-19 Testing Partner for Barbados; Will Provide Rapid Testing Services for Travelers from U.S. and Canada
November 13, 2020 (Source) — StageZero Life Sciences, Ltd (TSX:SZLS) (“StageZero” or the “Company”) announced today that it…
-
DIAGNOS Announces the Resumption of Screening Operations in Saudi Arabia and Conveys Congratulations to Dr. Salman Abdullah Al-Mutairi for his Assignment as Secretary General of the Council of Private Associations of the Kingdom
November 12, 2020 (Source) — Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB: DGNOF), a leader in early…
-
Valeo Pharma announces Amikacin approval in CANADA and U.S. launch of Ethacrynate Sodium
November 12, 2020 (Source) — Amikacin receives Health Canada approval, commercialization to start in first half of 2021…
-
Perimeter Medical Imaging AI to Present at Upcoming Virtual Investor Conferences
November 11, 2020 (Source) — Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC) (“Perimeter” or the “Company”), a medical technology…
-
Predictmedix Is Partnering With McGill Researchers for Clinical Research
November 10, 2020 (Source) — Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that the company is…
-
XPhyto Secures Exclusive Psychedelic Drug Development Agreement
November 10, 2020 (Source) — Psilocybin, mescaline, LSD, MDMA, DMT and other psychedelic compounds added to exclusive dealing…
-
9071-8776 Quebec Inc. Acquires Further Interest in DIAGNOS Inc.
November 5, 2020 (Source) — In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK)…
